K983281 is an FDA 510(k) clearance for the APOB. This device is classified as a Lipoprotein, Low-density, Antigen, Antiserum, Control (Class II - Special Controls, product code DFC).
Submitted by Abbott Laboratories (Irving, US). The FDA issued a Cleared decision on January 26, 1999, 130 days after receiving the submission on September 18, 1998.
This device falls under the Immunology FDA review panel. Regulated under 21 CFR 866.5600.
| 510(k) Number | K983281 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | September 18, 1998 |
| Decision Date | January 26, 1999 |
| Days to Decision | 130 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Summary PDF |
| Product Code | DFC — Lipoprotein, Low-density, Antigen, Antiserum, Control |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 866.5600 |